Showing results (221-230 of 237) with videos related to
Sort By:
Pageof 24
Oncotarget|April 28, 2015
Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinomaPrashant Kumar, Sayantani Nandi, Tuan Zea Tan, et al.Nature Communications|September 27, 2019
c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progressionWen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, et al.Nature Communications|November 10, 2019
Author Correction: c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progressionWen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, et al.European Journal of Cancer (Oxford, England : 1990)|October 31, 2025
International expert consensus on the clinical integration of circulating tumor cells in solid tumorsEleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.EMBO Molecular Medicine|May 14, 2013
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerTuan Zea Tan, Qing Hao Miow, Ruby Yun-Ju Huang, et al.Journal of Translational Medicine|April 19, 2015
Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenibAndrea Li Ann Wong, Joline Si Jing Lim, Arvind Sinha, et al.JCI Insight|October 5, 2016
PRL3-zumab, a first-in-class humanized antibody for cancer therapyMin Thura, Abdul Qader Omer Al-Aidaroos, Wei Peng Yong, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2020
AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer CellsMaria L Lotsberg, Katarzyna Wnuk-Lipinska, Stéphane Terry, et al.The Journal of Clinical Investigation|May 3, 2022
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancerMathieu Rouanne, Julien Adam, Camélia Radulescu, et al.EMBO Molecular Medicine|July 16, 2020
Characterization of circulating breast cancer cells with tumorigenic and metastatic capacityClaudia Koch, Andra Kuske, Simon A Joosse, et al.Pageof 24